Invention Grant
- Patent Title: Escherichia coli bacteriophage Esc-COP-7, and use thereof for suppressing proliferation of pathogenic Escherichia coli
-
Application No.: US16464875Application Date: 2017-09-29
-
Publication No.: US11412760B2Publication Date: 2022-08-16
- Inventor: Seong Jun Yoon , Soo Youn Jun , Hyoun Rok Paik , Jee Soo Son , SAng Hyeon Kang
- Applicant: INTRON BIOTECHNOLOGY, INC.
- Applicant Address: KR Gyeonggi-do
- Assignee: INTRON BIOTECHNOLOGY, INC.
- Current Assignee: INTRON BIOTECHNOLOGY, INC.
- Current Assignee Address: KR Gyeonggi-do
- Agency: Ballard Spahr LLP
- Priority: KR10-2016-0161320 20161130
- International Application: PCT/KR2017/010955 WO 20170929
- International Announcement: WO2018/101594 WO 20180607
- Main IPC: A61K35/76
- IPC: A61K35/76 ; A23K10/16 ; A23K30/18 ; C12N7/00 ; A01N63/40
Abstract:
The present invention relates to a Myoviridae bacteriophage ESC-COP-7 (accession number KCTC 13130BP) isolated from nature, and a method for preventing and treating infections from pathogenic Escherichia coli by means of a composition containing the Myoviridae bacteriophage ESC-COP-7 as an active ingredient, the Myoviridae bacteriophage ESC-COP-7 being characterized by having the capability to specifically kill Escherichia coli, and genome expressed by the SEQ ID 1.
Public/Granted literature
Information query
